drugset / Trial / NCT00432510
Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
RandomizedParallel-groupOpen-labelOther
Summary
The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1 esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not experiencing an HAE attack.
Timeline
- Start
- 2006-10-09
- Primary completion
- 2007-02-28
- Completion
- 2007-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CINRYZE | Protein / enzyme biologic | 1000 iu | Intravenous |